Luba Yammine, an addiction researcher, has suggested that the part of the brain responsible for food cravings may also play a role in cravings for substances of abuse. As drugs like Ozempic and Mounjaro have become more prevalent, patients have reported unexpected side effects such as reduced desire to smoke or drink. GLP-1 agonists can help reduce insulin resistance and improve fertility in patients, but further research is needed to understand their effects on pregnancy and addiction. In the medical field, Christian Hendershot, an addiction researcher, notes that there are limited medications available for treating addiction, and patients often struggle to access them. Additionally, addiction research receives less funding compared to other diseases.
